The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH

Pigment Cell Research

Volumn 14, Issue 2, 2001, Pages 86-93

  Brilliant, Murray H ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Pigmentation genes; Tyrosinase positive albinism

Indexed keywords

CARRIER PROTEIN; MEMBRANE PROTEIN; OCA2 PROTEIN, HUMAN; P PROTEIN, MOUSE;

ANIMAL; CHEMISTRY; GENETICS; HAPPY PUPPET SYNDROME; HUMAN; MELANOCYTE; METABOLISM; MOUSE; OCULAR ALBINISM; PH; PIGMENT DISORDER; PIGMENTATION; PRADER WILLI SYNDROME; REVIEW;

ALBINISM, OCULOCUTANEOUS; ANGELMAN SYNDROME; ANIMALS; CARRIER PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; MELANOCYTES; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; PIGMENTATION; PIGMENTATION DISORDERS; PRADER-WILLI SYNDROME;

AGOUTI; ANIMALIA; RODENTIA;

EID: 0035088810     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2001.140203.x     Document Type: Review

References (112)

1. Melanin: A two edged sword?
2. The toxicology and pharmacology of melanins
3. Melanosomes are specialized members of the lysosomal lineage of organelles
4. Lysosome-related organelles
5. Isolation and sequence of a cDNA locus for human tyrosinase that maps at the mouse c-albino locus
6. Enzymatic control of pigmentation in mammals
7. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase
8. Regulation of melanin formation
9. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation
10. pH-dependent interconvertible allosteric forms of murine melanoma tyrosinase. Physiological implications
11. pH of melanosomes of B16 murine melanoma is acidic: Its physiological importance in the regulation of melanin biosynthesis
12. Lag kinetics of tyrosinase: Its physiological implications
13. The pink-eyed dilution gene and the molecular pathogenesis of tyrosinase-positive albinism (OCA2)
14. Molecular basis of albinism: Mutations and polymorphisms of pigmentation genes associated with albinism
15. The original pink-eyed dilution mutation (p) arose in Asiatic mice: Implications for the H4 minor histocompatibility antigen, Myod1 regulation and the origin of inbred strains
16. Spontaneous somatic reversion in mice. Effects of parental genotype on stability at the p-locus
17. Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning
18. High-frequency genetic reversion mediated by a DNA duplication: The mouse pink-eyed unstable mutation
19. J alleles of the pink-eyed dilution locus
20. The mouse pink-eyed dilution gene: Association with human Prader - Willi and Angelman syndromes
21. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism
22. Organization and sequence of the human P gene and identification of a new family of transport proteins
23. A receptor subunit genes is deleted in a neurological mutant of the mouse p locus
24. Concordance between isolated cleft palate in mice and alterations within a region including the gene encoding the beta 3 subunit of the type A gamma-aminobutyric acid receptor
25. Phenotypic consequences of deletion of the gamma 3, alpha 5, or beta 3 subunit of the type A gamma-aminobutyric acid receptor in mice
26. Deficiency of the beta 3 subunit of the type A gamma-aminobutyric acid receptor causes cleft palate in mice
27. Molecular analysis of 36 mutations at the mouse pink-eyed dilution (p) locus
28. A very large protein with diverse functional motifs is deficient in rjs (runty, jerky, sterile) mice
29. The ancestral gene for transcribed, low-copy repeats in the Prader - Willi/Angelman region encodes a large protein implicated in protein trafficking, which is deficient in mice with neuromuscular and spermiogenic abnormalities
30. Molecular characterization of radiation- and chemically induced mutations associated with neuromuscular tremors, runting, juvenile lethality, and sperm defects in jdf2 mice
31. 100H myopathy, heart block and sudden neonatal death
32. Genetic and molecular analysis of recessive alleles at the pink-eyed dilution locus
33. Complementation analyses for 45 mutations encompassing the pink-eyed dilution (p) locus of the mouse
34. The mouse pink-eyed dilution locus: A model for aspects of Prader - Willi syndrome, Angelman syndrome, and a form of hypomelanosis of Ito
35. A quantitative histological study of the pigment found in the coat-color mutants of the house mouse. IV. The nature of the genic effects of five major allelic series
36. Comparative analysis of melanins and melanosomes produced by various coat color mutants
37. Chemical characterization of hair melanins in various coat color mutants of mice
38. The effects of genotype and cell environment on melanoblast differentiation in the house mouse
39. The fine structure of melanogenesis in coat-color mutants of the mouse
40. Gene expression at the pink-eyed dilution (p) locus in the mouse is confirmed to be pigment cell autonomous using recombinant embryonic skin grafts
41. Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene
42. Interaction of melanosomal proteins with melanin
43. Pink-eyed dilution (p) gene in rodents: Increased pigmentation in tissue culture
44. Melanosomal defects in melanocytes from mice lacking expression of the pink-eyed dilution gene: Correction by culture in the presence of excess tyrosine
45. Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes
46. Melansomal tyrosine transport in normal and pink-eyed dilution murine melanocytes
47. pH-dependent interconversion of two forms of tyrosinase in human skin
48. Regulation of melanogenesis in melanocytes
49. Chloride channels of intracellular organelles
50. Acidification of lysosomes and endosomes
51. pH and the recycling of transferring during receptor-mediated endocytosis
52. Aberrant pH of melanosomes in pink-eyed dilution (p) mutant melanocytes
53. A 46 kDa integral membrane protein from Mycobacterium leprae resembles a number of bacterial and mammalian membrane transport proteins
54. Molecular cloning and functional analysis of SUT-1, a sulfate transporter from human high endothelial venules
55. The complete DNA sequence of yeast chromosome III
56. Visualization of acidic organelles in intact cells by electron microscopy
57. Vesicles and cisternae in the trans Golgi apparatus of human fibroblasts are acidic compartments
58. Tyrosinases from two different loci are expressed by normal and by transformed melanocytes
59. Biosynthesis and intracellular movement of the melanosomal membrane glycoprotein gp75, the human b (brown) locus product
60. Synthesis and degradation of tyrosinase in cultured melanoma cells
61. Stimulation of tyrosinase activity of cultured melanoma cells by lysosomotropic agents
62. Stimulation by ionophores of tyrosinase activity of mouse melanoma cells in culture
63. Electron microscopic evidence for stimulation of melanosomal maturation by lysosomotropic agents and monensin in cultured B16 mouse melanoma cells
64. (+)-ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma cells
65. un) mutation
66. The pink-eyed dilution protein and the eumelanin/pheomelanin switch: In support of a unifying hypothesis
67. The pink-eyed dilution locus controls the biogenesis of melanosomes and levels of melanosomal proteins in the eye
68. Albinism
69. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene
70. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader - Willi Syndrome plus albinism
71. Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2)
72. African origin of an intragenic deletion of the P gene in tyrosinase positive oculocutaneous albinism
73. The mouse pink-eyed dilution gene: Association with hypopigmenation in Prader - Willi and Angelman syndromes, and with human OCA2
74. Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: Distribution of the 2.7 kb deletion allele of the P gene
75. Oculocutaneous albinism in an isolated Tonga community in Zimbabwe
76. Mutations of the human P gene associated with Type II Oculocutaneous Albinism (OCA2)
77. Pigmented skin lesions in tyrosinase-positive oculocutaneous albinos: A study in black South Africans
78. Inherited disorders of pigmentation
79. The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12
80. The tyrosinase-positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in southern African negroids
81. An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in southern African Negroids
82. Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2)
83. Oculocutaneous albinism (OCA2) in sub-Saharan Africa: Distribution of the common 2.7-kb P gene deletion mutation
84. Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa
85. Estimation of carrier frequency of a 2.7 kb deletion allele of the P gene associated with OCA2 in African-Americans
86. Hopi Indians, inbreeding, and albinism
87. Tyrosinase positive oculocutaneons albinism among the Zuni and the Brandywine triracial isolate: Biochemical and clinical characteristics and fertility
88. Novel mutations of the P gene in type II oculocutaneous albinism (OCA2)
89. Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences
90. Human pigmentation genetics: The difference is only skin deep
91. Assignment of genes coding for brown eye colour (BEY2) and brown hair colour (HCL3) on chromosome 15q
92. Molecular characterization of two proximal deletion breakpoint regions in both Prader - Willi and Angelman syndrome patients
93. Genetic abnormalities in Prader - Willi syndrome and lessons from mouse models
94. The spectrum of mutations in UBE3A causing Angelman syndrome
95. Angelman syndrome: A review of clinical and genetic aspects
96. Familial Prader - Willi syndrome: Case report and a literature review
97. Ocolocutaneous albinoidism as a manifestation of reduced neural crest derivatives in the Prader - Willi syndrome
98. Hypopigmentation in the Prader - Willi Syndrome
99. Hypopigmentation: A common feature of Prader - Willi syndrome
100. Hypopigmentation in Angelman syndrome
101. Clinical research on Angelman syndrome in the United Kingdom: Observations on 82 affected individuals
102. Molecular and clinical study of 61 Angelman syndrome patients
103. DNA deletion and its parental origin in Angelman syndrome patients
104. Hypopigmentation in the Prader - Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele
105. Abnormalities of the central visual pathways in Prader - Willi syndrome associated with hypopigmentation
106. Diagnosis of Angelman syndrome in infants
107. Synchrony of oculocutaneous albinism, the Prader - Willi syndrome, and a normal karyotope
108. Clinical features in 27 patients with Angelman syndrome resulting from DNA deletion
109. Oculocutaneous albinism type 2 with a P gene missense mutation in a patient with Angelman syndrome
110. Mosaic loss of 15q11q13 in a patient with hypomelanosis of Ito: Is there a role for the P gene?
111. Hypomelanosis of Ito: Clinical syndrome or just phenotype?